Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BioGaia

99.05

 

SEK

 

-4.48 %

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
-4.48%
-3.37%
-20.44%
-11.48%
-7.43%
-21.01%
+1.69%
-2.51%
+1,294.42%

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Read more
Market cap
10.02B SEK
Turnover
154.32M SEK
Revenue
1.42B
EBIT %
29.76 %
P/E
28.46
Dividend yield-%
6.97 %
Financial calendar
18/7
2025

Interim report Q2'25

22/10
2025

Interim report Q3'25

All
Webcasts
Press releases
ShowingAll content types
Regulatory press releaseyesterday

Change in the number of votes in BioGaia AB (publ)

BioGaia
Regulatory press releaseyesterday

Förändrat antal röster i BioGaia AB (publ)

BioGaia
Regulatory press release5/21/2025, 12:03 PM

Finansinspektionen: Flaggningsmeddelande i BioGaia AB

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/20/2025, 11:01 AM

Finansinspektionen: Flaggningsmeddelande i BioGaia AB

BioGaia
Regulatory press release5/14/2025, 2:43 PM

Finansinspektionen: Flaggningsmeddelande i BioGaia AB

BioGaia
Regulatory press release5/12/2025, 2:38 PM

Finansinspektionen: Flaggningsmeddelande i BioGaia AB

BioGaia
Regulatory press release5/7/2025, 4:30 PM

Årsstämma i BioGaia

BioGaia
Regulatory press release5/7/2025, 4:30 PM

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast with teleconference, Q1'25
Webcast5/7/2025, 7:30 AM

BioGaia, Audiocast with teleconference, Q1'25

BioGaia
Regulatory press release5/7/2025, 6:00 AM

BioGaia AB: Interim Management Statement January - March 2025

BioGaia
Regulatory press release5/7/2025, 6:00 AM

BioGaia AB: Delårsredogörelse januari - mars 2025

BioGaia
Regulatory press release4/2/2025, 8:30 AM

Kallelse till årsstämma i BioGaia AB (publ)

BioGaia
Regulatory press release4/2/2025, 8:30 AM

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Regulatory press release3/26/2025, 10:00 AM

BioGaias Års- och hållbarhetsredovisning 2024 publicerad

BioGaia
Regulatory press release3/26/2025, 10:00 AM

BioGaia Annual and Sustainability Report 2024 published

BioGaia
Regulatory press release3/20/2025, 8:30 PM

Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder

BioGaia
Regulatory press release3/20/2025, 8:30 PM

Ägarförändring i BioGaia: Anatom, ett Schweizbaserat långsiktigt investeringsbolag, blir ny huvudägare

BioGaia
BioGaia, Audiocast with teleconference, Q4'24
Webcast2/12/2025, 8:30 AM

BioGaia, Audiocast with teleconference, Q4'24

BioGaia
Regulatory press release2/12/2025, 7:00 AM

BioGaia AB: Bokslutskommuniké januari - december 2024

BioGaia
Regulatory press release2/12/2025, 7:00 AM

BioGaia AB: Year-end report January - December 2024

BioGaia
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team